NEU 5.30% $15.11 neuren pharmaceuticals limited

Share Price, page-10317

  1. 6,169 Posts.
    lightbulb Created with Sketch. 1643
    Well said KJT (system won't let me reply directly) - the most reasoned, sensible predictive post I have come across on this forum. IMO, you have clearly set out an argument that is supported by post Daybue approval SP fluctuations.Despite the huge potential ahead, it is just that -potential. At the non speculative end of the market revenue $$$'s dominate and the actualisation of Neuren's $$$'s potential is still many years off, if it is to be achieved at all.IMO, quick SP appreciation from here will only come via a takeover offer, rather than 2591 trial results alone. IMO, those hoping for a $50 plus SP within the next couple of years, will be sadly disappointed.
 
watchlist Created with Sketch. Add NEU (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.